New Zealand is good for clinical trials of new treatments and drugs, but a number of barriers are holding back clinical trials in New Zealand, said a panel of speakers at NZBio conference in Auckland today.
Listen to the podcast below to hear their views on what needs to happen to encourage more drug companies to base trials in New Zealand.
Dr Paul Hutchison, MP, Chair of the health parliamentary select committee
Jan Campbell, medical director, Roche
Matt Kepple, managing director, Primorus Clinical Trials